These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 9123417)

  • 1. Retransplantation and reversibility of chronic vascular rejection.
    Zheng SX; Forbes RD; Gomersall M; Guttmann RD
    Transplant Proc; 1997; 29(1-2):1541. PubMed ID: 9123417
    [No Abstract]   [Full Text] [Related]  

  • 2. Role of ICAM-1 in chronic rejection in the rat heart transplantation model.
    Hamano K; Ito H; Suzuki K; Shirasawa B; Gohra H; Katoh T; Fujimura Y; Tsuboi H; Esato K
    Transplant Proc; 1996 Jun; 28(3):1822. PubMed ID: 8658899
    [No Abstract]   [Full Text] [Related]  

  • 3. Impact of natural killer cells and macrophages on the course of acute graft rejection following allogeneic heart transplantation in the rat.
    Dresske B; Zhu X; Peters J; Brötzmann K; Fändrich F
    Transplant Proc; 1996 Dec; 28(6):3259-60. PubMed ID: 8962264
    [No Abstract]   [Full Text] [Related]  

  • 4. Chronic rejection of organ allografts may arise from injuries sustained in recurring foci of acute rejection that resolve spontaneously.
    Lowry RP; Takeuchi T; Cremisi H; Konieczny B; Someren A
    Transplant Proc; 1993 Apr; 25(2):2103-5. PubMed ID: 8470286
    [No Abstract]   [Full Text] [Related]  

  • 5. Cyclosporine and the reversibility of chronic vascular rejection.
    Guttmann RD; Forbes RD; Zheng S; Busque S
    Transplant Proc; 1994 Oct; 26(5):2564-6. PubMed ID: 7940792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunosuppressive effect of RS-61443 on rat cardiac allograft survival in combination with leflunomide or FK 506.
    D'Silva M; Antoniou E; DeRoover A; Nishimura Y; Howie A; McMaster P
    Transplant Proc; 1996 Apr; 28(2):930-1. PubMed ID: 8623467
    [No Abstract]   [Full Text] [Related]  

  • 7. Chronic vascular rejection in an inbred rat cardiac model.
    Forbes RD; Gomersall M; Guttmann RD
    Transplant Proc; 1991 Feb; 23(1 Pt 1):613-4. PubMed ID: 1990625
    [No Abstract]   [Full Text] [Related]  

  • 8. Adverse effect of rhG-CSF in the process of rat heart allograft rejection.
    Tamaki T; Tanaka M; Konoeda Y
    Transplant Proc; 1994 Aug; 26(4):2311-2. PubMed ID: 7520630
    [No Abstract]   [Full Text] [Related]  

  • 9. Early acute rejection episodes are reversible following retransplantation into a syngeneic donor and do not progress to chronic rejection.
    Tullius SG; Nieminen M; Bechstein WO; Jonas S; Steinmüller T; Pratschke J; Volk HD; Neuhaus P
    Transplant Proc; 1997 Nov; 29(7):3034-5. PubMed ID: 9365657
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of hemodynamics on graft rejection in the heterotopic heart transplantation model.
    Lange V; Gassel AM; Deuse T; Ulrichs K; Silber RE
    Transplant Proc; 1998 Jun; 30(4):1014-6. PubMed ID: 9636410
    [No Abstract]   [Full Text] [Related]  

  • 11. Retransplantation reverses mononuclear infiltration but not myointimal proliferation in a rat model of chronic cardiac allograft rejection.
    Schmid C; Heemann U; Tilney NL
    Transplantation; 1996 Jun; 61(12):1695-9. PubMed ID: 8685945
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of cyclosporine on chronic vascular rejection in an inbred rat cardiac model.
    Forbes RD; Gomersall M; Guttmann RD
    Transplant Proc; 1993 Feb; 25(1 Pt 1):530-1. PubMed ID: 8438402
    [No Abstract]   [Full Text] [Related]  

  • 13. Coronary arteriosclerosis did not occur in the transplanted hearts of tolerance-induced rats: analysis from platelet-derived growth factor expression.
    Ito H; Hamano K; Gohra H; Katoh T; Fujimura Y; Zempo N; Esato K
    Transplant Proc; 1998 Nov; 30(7):3871-2. PubMed ID: 9838694
    [No Abstract]   [Full Text] [Related]  

  • 14. Rejection pattern of cardiac and skeletal muscle allografts: implications for surveillance of cardiac rejection.
    Benedetti E; Blanchard J; Sekosan M; Raofi V; Dunn T; Lutrin F; Massad M
    Transplant Proc; 1998 Aug; 30(5):1929. PubMed ID: 9723338
    [No Abstract]   [Full Text] [Related]  

  • 15. Spectrum of susceptibility to rejection of heart and multivisceral small bowel allografts using leflunomide immunosuppression.
    D'Silva M; DeRoover A; Nishimura Y; Antoniou E; Candinas D; Hubscher SG; McMaster P
    Transplant Proc; 1996 Apr; 28(2):948-9. PubMed ID: 8623475
    [No Abstract]   [Full Text] [Related]  

  • 16. The time pattern of organ infiltration and distribution of natural killer cells and macrophages in the course of acute graft rejection after allogeneic heart transplantation in the rat.
    Dresske B; Zhu X; Herwartz C; Brötzmann K; Fändrich F
    Transplant Proc; 1997 May; 29(3):1715-6. PubMed ID: 9142243
    [No Abstract]   [Full Text] [Related]  

  • 17. Development of tolerance in a chronic rejection model.
    Tullius SG; Nieminen M; Bechstein WO; Jonas S; Rayes N; Qun Y; Volk HD; Neuhaus P
    Transplant Proc; 1998 Jun; 30(4):1075-6. PubMed ID: 9636436
    [No Abstract]   [Full Text] [Related]  

  • 18. Active cell migration in retransplanted rat cardiac allografts during the course of chronic rejection.
    Kitagawa-Sakakida S; Tori M; Li Z; Horiguchi K; Izutani H; Matsuda H; Shirakura R
    J Heart Lung Transplant; 2000 Jun; 19(6):584-90. PubMed ID: 10867339
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The influence of immunosuppression on organ pressure measured in rejecting heart and kidney transplants.
    Vasir BS; Hohmeier H; Salaman JR
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1066. PubMed ID: 3274279
    [No Abstract]   [Full Text] [Related]  

  • 20. Tissue-specific immune response: the role of innate immunity in small bowel and heart transplantation.
    Dresske B; Zavazava N; Brötzmann K; Kremer B; Fändrich F
    Transplant Proc; 1998 Sep; 30(6):2566-7. PubMed ID: 9745490
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.